Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

TNMG vs CYAB: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

TNMG Wins Head-to-Head Institutional Verdict (3–0 across 6 Pillars · 7–1 Matrix Metrics)

TNMG Overall Winner 6-Pillar Tally: TNMG 3 – 0 CYAB (3 Tie) Matrix Metrics: TNMG 7 – 1 CYAB

As of Nov 20, 2026, TNL Mediagene (TNMG) is the stronger overall head-to-head candidate over CYAB (CYAB) in the Tradestie Institutional Equity Comparison Engine, winning 7–1 core matrix metrics and 3–0 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). TNMG carries a Unified Composite Score of 48.1/100 (HOLD) at $2.12 (N/M Forward P/E, -100.6% operating margin), whereas CYAB carries 48.4/100 (HOLD) at $0.06 (N/M Forward P/E, N/A operating margin).

  • Technical & Structure Timing Caution: TNMG trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 33.6); meanwhile CYAB is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About TNMG vs CYAB
TNMG NASDAQ Head-to-Head Winner
TNL Mediagene Ordinary Shares
Services-Advertising
$2.12
-7.42% 1D
Market Cap $1.7M
TTM Revenue $50M
Forward P/E N/M
Beta / 30D Vol -0.58β · 135% Vol
Unified Composite Score
48.1 / 100 HOLD
Tech 33.0 Fund 48.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 34
RSI-14: 33.6 · SMA20: $2.96 · SMA50: $3.42
CYAB US Equity
CYAB
Institutional Equity
$0.06
-3.39% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.45β · 246% Vol
Unified Composite Score
48.4 / 100 HOLD
Tech 43.0 Fund 52.0 Flow 50.0 Mom 88.9
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -37.4%), weak momentum, RSI 32
RSI-14: 32.2 · SMA20: $0.10 · SMA50: $0.17

6-Pillar Scorecard Institutional Category Breakdown (TNMG 3 – 0 CYAB)

Columns: Metric · TNMG · CYAB
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale TNMG
Revenue Growth (YoY) +5.7% N/A
Earnings Growth (YoY) +0.0% N/A
TTM Revenue (USD) $50M N/A
Market Cap $1.7M N/A
3. Profitability & Quality TNMG
Gross Margin 33.3% N/A
Operating Margin -100.6% N/A
Net Profit Margin -167.9% N/A
Return on Equity (ROE) -164.6% N/A
4. Balance Sheet & Cash Flow TNMG
Cash Generation (TTM) -$48M EBITDA N/A
Cash Flow Margin -96.6% EBITDA Mgn N/A
Net Cash / Leverage $109.10 Book/Sh · -164.6% ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Publishing Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: TNMG (7) vs CYAB (1)
Institutional Metric TNMG CYAB Criterion Row Edge
Market Capitalization
Scale
$1.7M N/A Larger Scale TNMG
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+5.7% N/A Higher Growth TNMG
Operating Margin (TTM)
Profitability
-100.6% N/A Higher Margin TNMG
Net Profit Margin
Profitability
-167.9% N/A Higher Margin TNMG
Return on Equity (ROE)
Capital Efficiency
-164.6% N/A Higher ROE TNMG
52-Week Range Position
Momentum
28% ($0–$7) 0% ($0–$6) Stronger Trend TNMG
Beta / 30D Volatility
Risk Regime
-0.58β · 135% Vol 0.45β · 246% Vol Lower Realized Risk TNMG
Unified Institutional Score
Composite Signal
48.1 / 100 (HOLD) 48.4 / 100 (HOLD) Higher Composite CYAB
Trailing 12M Revenue (USD)
Operating Scale
$50M N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
33.3% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$48M EBITDA ($109.10 Book/Sh · -164.6% ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon TNMG +23.7 pp
TNMG: -32.48% · CYAB: -56.18%
3M Horizon TNMG +512.18 pp
TNMG: +432.93% · CYAB: -79.25%
6M Horizon TNMG +280.95 pp
TNMG: +191.89% · CYAB: -89.06%
1Y Horizon TNMG +112.89 pp
TNMG: +14.59% · CYAB: -98.3%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on TNMG vs CYAB. Trailing 12-month operating profitability (TNMG -100.6% vs CYAB N/A) and valuation multiples (TNMG N/M vs CYAB N/M Forward P/E) are benchmarked directly in Pillar 4 below.

TNMG ADR TTM Benchmark FX-Normalized USD
TTM Revenue$50M
Gross Margin33.3%
Op. Margin-100.6%
ROE / Fwd P/E-164.6% · N/M
CYAB ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
TNMG UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact TNMG Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CYAB UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CYAB Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
TNMG Moat Profile Cyclical / Execution-Driven Positioning
Publishing Operator
Competes within the Publishing value chain with $1.7M market capitalization and -100.6% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
CYAB Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ TNMG vs CYAB Key Questions & Quantitative Answers

As of Nov 20, 2026, TNL Mediagene (TNMG) is the stronger overall head-to-head candidate over CYAB (CYAB) in the Tradestie Institutional Equity Comparison Engine, winning 7–1 core matrix metrics and 3–0 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). TNMG carries a Unified Composite Score of 48.1/100 (HOLD) at $2.12 (N/M Forward P/E, -100.6% operating margin), whereas CYAB carries 48.4/100 (HOLD) at $0.06 (N/M Forward P/E, N/A operating margin). Technical & Structure Timing Caution: TNMG trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 33.6); meanwhile CYAB is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

TNMG leads the Growth & Scale pillar: TNMG posts +5.7% YoY revenue growth and +0.0% YoY earnings growth on $50M TTM revenue (33.3% gross margin, -100.6% operating margin), compared with CYAB at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, TNMG generates $50M in USD-normalized revenue versus N/A for CYAB. In operating R&D and SG&A reinvestment, TNMG deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for CYAB.

TNMG and CYAB trade at balanced relative valuation multiples. TNMG trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (-96.6% EBITDA margin), whereas CYAB trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against TNMG (-164.6% ROE) versus CYAB (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, TNMG carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.58β · 135% Vol realized risk). By comparison, CYAB carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.45β · 246% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.